Why the study?
Does IRAK4 signaling exacerbate viral myocarditis?
Does IRAK4 signaling exacerbate viral myocarditis?
IRAK4 exacerbates viral myocarditis by inhibiting interferon production and reducing protective monocyte mobilization, suggesting IRAK4 inhibitors as a potential future therapy.
May support IRAK4 inhibition in viral myocarditis; hypothesis-generating in animals, translation to humans remains open.
Innate immunity signal transducer IRAK4 exacerbates viral myocarditis through inhibition of interferon production and reduced mobilization of protective CCR5(+) monocytes/macrophages to the heart. The combination of IRAK4 inhibitors and antiviral adjuvants may become an attractive therapeutic approach against viral myocarditis in the future.
No takes yet. Share an insight, caveat, or question.
Valaperti et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: